Prof. Elke Jaeger is one of Germany's top oncologists according to Focus rating – she leads Oncology and Hematology at Nordwest Clinic.
Dr. Michael Shapira specializes exclusively in bone marrow transplantation at Sourasky Medical Center – a leader in hematologic treatments.
Dr. Fredi Aviv brings over 34 years of experience of focused practice as an oncohematologist at Tel Aviv's leading Sourasky Medical Center.
Dr. Litleaungdej is a hematology specialist trained at Thammasat University, focusing on blood disorders including acute lymphoblastic leukemia.
Specializes in Medical Oncology with extensive training from Akdeniz University – Dr. Alemdar focuses on acute lymphoblastic leukemia.
Dr. Dror Levin directs the pediatric hematology oncology department at Sourasky Medical Center in Tel Aviv, one of Israel's top hospitals.
Trained at Duke University and Fred Hutchinson Cancer Research Center – Dr. Gulsan specializes in stem cell transplantation for acute lymphoblastic leukemia.
Professor Hilmi Apak specializes in pediatric hematology and oncology, with a strong focus on acute lymphoblastic leukemia at Valued Med Hub Hospitals.
Dr. Herishanu has been recognized with multiple prestigious awards for his research into chronic lymphocytic leukemia.
Deputy Head of Clinical Oncology at Austria's largest hospital and an Associate Professor. Prof. Köstler is a leading expert in precise, personalized cancer therapy.
Prof. Hasan Atilla Ozkan brings 23 years of experience of hematology expertise, specializing in stem cell transplantation at VM Medical Park Pendik Hospital.
Professor Drach specializes in oncology with extensive experience at Vienna Medical University and directs the Josefstadt Private Clinic.
Head of Hematology at Nordwest Clinic with 36 years of experience of experience – Dr. Weidmann specializes in blood disorder treatments.
Prof. Avichai Shimoni, MD, is Director of Bone Marrow Transplantation at Sheba Medical Center. He is a hemato-oncologist with over 30 years of experience in bone marrow transplantation, cellular therapies, and advanced blood cancer care.
He leads a high-volume program for complex, high-risk blood cancers. He performs allogeneic and autologous transplants. He also provides CAR T-cell therapy for leukemia, lymphoma, and multiple myeloma. He completed a bone marrow transplantation fellowship at MD Anderson Cancer Center.
He is Chairman of Hematology at Tel Aviv University and a Professor of Hematology. He has authored more than 250 scientific papers. His research focuses on CAR T-cell therapy and stem cell transplantation. He is often listed among Israel's Best Doctors (Forbes 2025 and 2026).
Dr. Abraham Avigdor, MD, is Director of the Institute of Hematology and Co‑Director of the Hematology & Bone Marrow Transplantation Division at Sheba Medical Center. He is an international leader in lymphoma, CAR‑T, and advanced hemato‑oncology with more than 35 years of experience. His clinical focus includes lymphomas, multiple myeloma, and complex blood cancers.
He is a pioneer in CAR‑T integration. He leads cellular therapy and bone marrow transplantation programs (autologous and allogeneic). He also advances stem cell therapies and precision diagnostics, including PET/CT‑based prognostics. His work includes immunotherapy and targeted regimens and the development of innovative, data‑driven protocols.
He collaborates with LYSA, EMCL, and international PET groups. He has authored more than 130 publications. Key roles include Founder and President of the Israeli Lymphoma Working Group, former Chair of the Israeli Lymphoma Study Group, and Senior Lecturer at Tel Aviv University. Education: MD, Ben‑Gurion University; residency, Sheba Medical Center; postdoctoral fellowship, Weizmann Institute. Awards include the Knesset Prize, the Israeli Ministry of Health Award, and the Sackler Prize.
Dr. Hila Magen, MD, leads the Multiple Myeloma and Amyloidosis Unit at Sheba Medical Center. She is a hemato-oncologist with over 35 years of experience. She is a leading Israeli expert in multiple myeloma and plasma cell disorders.
She runs a program that provides personalized care and early access to clinical trials. This includes CAR-T therapy for high-risk and relapsed or refractory myeloma and amyloidosis. Dr. Magen is a principal investigator in point-of-care CAR-T studies. She brings new immunotherapies into routine care.
Training: Fellowships in Multiple Myeloma (UAMS) and Lymphocytic Leukemia (MD Anderson). Academic: Instructor, Tel Aviv University. Research: Author of 100+ publications, contributor to landmark myeloma studies, and reviewer for international journals.